Mechanism and regulation of the nonsense-mediated decay pathway.
Hug N, Longman D, Cáceres JF. · 2016
Read Mechanism and regulation of the nonsense-mediated decay pathway. by Hug N, Longman D, Cáceres JF. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4770240.txt.
Introduction
Nele Hug, Dasa Longman, and Javier F. Cáceres review the cell's faulty-message shredder in Nucleic Acids Research in 2016. The pathway, nonsense-mediated decay, destroys messenger RNAs that carry an early stop sign, which would otherwise build broken proteins. It also tunes the levels of many normal messages, so its strength must be held in check.
The review follows how the shredder spots a bad message and shifts from spotting to cutting, with helicase enzymes doing key work in that shift. It surveys fresh hunts for new helper factors and what each one does. It also takes stock of what the pathway does for the whole body, from development to disease. Buffer systems that cap the shredder's own strength get close attention.
Catalog record
| CREATOR | Hug N, Longman D, Cáceres JF. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mechanism and regulation of the nonsense-mediated decay pathway By Nele Hug, Dasa Longman, Javier F. Cáceres Published in: Nucleic Acids Research DOI: 10.1093/nar/gkw010 ABSTRACT The Nonsense-mediated mRNA decay (NMD) pathway selectively degrades mRNAs harboring premature termination codons (PTCs) but also regulates the abundance of a large number of cellular RNAs. The central role of NMD in the control of gene expression requires the existence of buffering mechanisms that tightly regulate the magnitude of this pathway. Here, we will focus on the mechanism of NMD with an emphasis on the role of RNA helicases in the transition from NMD complexes that recognize a PTC to those that promote mRNA decay. We will also review recent strategies aimed at uncovering novel trans-acting factors and their functional role in the NMD pathway. Finally, we will describe recent progress in the study of the physiological role of the NMD response. INTRODUCTION Cells have evolved different surveillance mechanisms to target messenger RNAs (mRNAs) with mutations that would otherwise lead to errors in the synthesis of proteins, and also to eliminate other incorrectly processed cellular RNAs. These mechanisms operate both in the cell nucleus and cytoplasm (1). One of the best-studied RNA surveillance pathways is the Nonsense-mediated decay (NMD) pathway, which targets mRNAs harboring premature termination codons (PTC) for degradation. This mechanism operates in the cytoplasm and is intimately linked to translation termination (2,3). Initially, NMD was described as a post-transcriptional mRNA quality control mechanism responsible for the removal of PTC-containing mRNAs, which if left intact, would lead to production of truncated proteins with predicted deleterious effects for the organism. From a medical perspective, this suggests that the NMD pathway has a role in the modulation of the phenotypic outcome of genetic disorders that are caused by the presence of a PTC (4,5). However, it has become evident in recent years that this pathway is not solely dedicated to the destruction of PTC-containing transcripts, but that it also has an important role in controlling the expression of naturally occurring transcripts (6–8) (Figure 1). This general role of the NMD pathway on gene expression requires the existence of buffering mechanisms to tightly regulate the magnitude of the NMD response upon environmental and/or genetic insults. Accordingly, a negative feedback regulatory network that controls the levels of core NMD factors operates in mammals (9,10), in nematodes and zebrafish (11), and also in plants (12). Interestingly, the magnitude of the NMD response has also been shown to be variable among individuals (13). The NMD pathway is not exclusively dedicated to mRNAs, as shown by the substantial number of long non-coding RNAs (lncRNAs) that are substrates of NMD in Arabidopsis, S. cerevisiae and mouse ES cells (14–16). This is not entirely surprising, taking into account the recently revealed association of the translation machinery with lncRNAs (17). [Figure: Dual role of the Nonsense-mediated decay (NMD) pathway. NMD degrades PTC-containing transcripts (‘faulty’ transcripts) (top panel) and also regulates the expression of naturally occurring transcripts (‘normal transcripts’), acting as a fine-tuning mechanism of gene expression (bottom panel). Green spheres represent both ribosomal subunits, whereas red circles depict the core NMD factor, UPF1.] In this article, we will cover recent advances regarding the NMD mechanism, building on the roles of core NMD factors, the functions of RNA helicases in NMD complex assembly, as well as recent strategies used to identify novel NMD factors. Finally, we will review the crucial role of the NMD mechanism in buffering gene expression and its impact on cell physiology. PTC definition A crucial aspect of the NMD pathway is the ability to distinguish normal termination codons from PTCs. Despite the relatively high conservation of NMD core factors across evolution, the mechanism of PTC definition varies across different species. In mammals, NMD is intimately linked to pre-mRNA splicing, and mRNAs harboring a PTC 50 to 55 nucleotides upstream of the final exon–exon junction are efficiently degraded (18–21). This is signaled by the presence of the exon junction complex (EJC), a multi-subunit protein complex, which is deposited 20 to 24 nucleotides upstream of an exon–exon junction during pre-mRNA splicing (22,23). The EJC remains associated to the mRNA until it is displaced by the translation machinery with the help of the ribosome-associated protein PYM acting as an EJC disassembly factor (24,25,26). Recent transcriptome-wide analysis of EJC deposition established that EJCs are not equally assembled at every exon junction, as previously hypothesized (27,28); indeed, approximately half of all EJCs are present at non-canonical positions (29). A remaining challenge is to understand whether the observed variation on EJC loading affects NMD efficiency. By contrast, PTC definition occurs independently of exon boundaries in S. cerevisiae, where the distance between the PTC and the 3′ end defines NMD, as proposed by the faux 3′ UTR model (30,31). In Schizosaccharomyces pombe splicing enhances NMD; however, EJC components are not required for NMD and what seems to enhance NMD is the proximity of the intron to the PTC (32). The presence of introns is also not required to define PTCs in Drosophila or in C. elegans, exposing a significant level of mechanistic diversity in this critical step of the NMD process (33,34). NMD mechanism and the role of RNA helicases in NMD progression The initial identification of factors with roles in the NMD pathway was achieved by means of unbiased genetic screens in Caenorhabditis elegans and Saccharomyces cerevisiae. This led to the identification of seven genes in nematodes, termed smg-1–7 (suppressor with morphological effect on genitalia), given that mutations of these genes led to abnormal morphogenesis of the male bursa and the hermaphrodite vulva (35,36). Importantly, smg mutant worms are viable, indicating that NMD is not essential in nematodes. Similarly, three genes, termed UPF1–3 (for up-frameshift), that are orthologues of C. elegans smg-2, smg-3 and smg-4 genes, were identified in S. cerevisiae (37,38). Homology searches led to the identification of orthologous genes in other species, including Arabidopsis, Drosophila and mammals (39). RNA helicases have a central role in the mechanism of NMD progression. In general, these enzymes can use adenosine triphosphate (ATP) to translocate along nucleic acids, potentially unwinding secondary structure and acting to remodel RNA-protein complexes. Alternatively, they might act as ‘‘place markers’’ remaining temporarily fixed in a defined position while signaling to, or directly recruiting, the degradation machinery (40,41). In the latter case, RNA helicases clamp the RNA in an ATP-dependent fashion to provide nucleation centers to assemble larger RNA-protein complexes. The central component of the NMD pathway in all organisms studied is the protein UPF1/SMG2, an ATP-dependent RNA helicase of the SF1 superfamily, which undergoes cycles of phosphorylation and dephosphorylation that are essential for NMD progression. Phosphorylation of UPF1 is carried out by the SMG1c complex, comprised of the protein kinase SMG1, a phosphoinositide 3-kinase (PI3K)-like kinase and two additional subunits, SMG8 and SMG9 (42–44). Initially, UPF1 associates with SMG1 and acts as a clamp, interacting directly with the eukaryotic release factors eRF1 and eRF3 to form the so-called surveillance complex (SURF) in the vicinity of the PTC (Figure 2). Two subunits of the SMG1c complex, SMG8 and the NTPase SMG9 associate tightly with SMG1 and regulate its activity through the induction of conformational changes, with SMG8 binding to the preformed SMG9-SMG1 complex and maintaining the